4//SEC Filing
PHARMACEUTICAL PRODUCT DEVELOPMENT INC 4
Accession 0001181154-06-000003
CIK 0001003124operating
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:07 PM ET
Size
27.1 KB
Accession
0001181154-06-000003
Insider Transaction Report
Form 4
DAVENPORT FRED B JR
President
Transactions
- Sale
Common Stock
2006-02-15$66.20/sh−2,500$165,500→ 66,366 total - Sale
Common Stock
2006-02-15$66.12/sh−1,500$99,180→ 61,366 total - Exercise/Conversion
Common Stock
2006-02-15$30.10/sh+25,000$752,500→ 68,866 total - Sale
Common Stock
2006-02-15$66.15/sh−2,000$132,300→ 55,866 total - Exercise/Conversion
Common Stock
2006-02-15$26.22/sh+5,000$131,100→ 43,866 total - Sale
Common Stock
2006-02-15$66.10/sh−7,500$495,750→ 38,866 total - Sale
Common Stock
2006-02-15$66.03/sh−1,000$66,030→ 65,366 total - Exercise/Conversion
Stock Options (to buy)
2006-02-15−25,000→ 165,000 totalExercise: $30.10From: 2005-01-15Exp: 2012-01-14→ Common Stock (25,000 underlying) - Exercise/Conversion
Stock Options (to buy)
2006-02-15−5,000→ 190,000 totalExercise: $26.22From: 2004-12-03Exp: 2011-12-02→ Common Stock (5,000 underlying) - Sale
Common Stock
2006-02-15$66.05/sh−5,000$330,250→ 48,866 total
Footnotes (1)
- [F1]8,333 shares were vested and exercisable on 1/15/03; 8,333 shares were vested and exercisable on 1/15/04 and 8,334 shares were vested and exercisable on 1/15/05.
Documents
Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT INC
CIK 0001003124
Entity typeoperating
IncorporatedNC
Related Parties
1- filerCIK 0001003124
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:07 PM ET
- Size
- 27.1 KB